Overview

Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to analyze the variation of adiponectinemia and its molecular forms in RA patients receiving tocilizumab therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon